These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

665 related items for PubMed ID: 15057410

  • 1. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U, Volkers P, Noeske K, Werner E.
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [Abstract] [Full Text] [Related]

  • 2. Control of Clostridium perfringens vaccines using an indirect competitive ELISA for the epsilon toxin component - examination of the assay by a collaborative study.
    Rosskopf-Streicher U, Volkers P, Werner E.
    Pharmeuropa Bio; 2004 Jan; 2003(2):91-6. PubMed ID: 14960265
    [Abstract] [Full Text] [Related]

  • 3. Replacement of the in vivo neutralisation test for efficacy demonstration of tetanus vaccines ad us. vet.
    Rosskopf U, Noeske K, Werner E.
    ALTEX; 2005 Jan; 22(3):169-74. PubMed ID: 16186992
    [Abstract] [Full Text] [Related]

  • 4. Modified toxin-binding inhibition (ToBI) test for epsilon antitoxin determination in serum of immunized rabbits.
    Sobrinho EM, Cangussu AS, Brandi IV, Sari RS, Almeida AC, Colen F, Quintilio W, Santos HO.
    Vet Immunol Immunopathol; 2010 Nov 15; 138(1-2):129-33. PubMed ID: 20709411
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
    Hauer PJ, Clough NE.
    Dev Biol Stand; 1999 Nov 15; 101():85-94. PubMed ID: 10566780
    [Abstract] [Full Text] [Related]

  • 7. Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringens beta and epsilon-toxoid containing veterinary vaccines.
    Ebert E, Oppling V, Werner E, Cussler K.
    FEMS Immunol Med Microbiol; 1999 Jul 15; 24(3):299-311. PubMed ID: 10397315
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The use of the toxin binding inhibition test for potency testing of Clostridium novyi type B alpha toxoid vaccines].
    Luick K, Gottschaldt J, Schulze F, Werner E, Erler W, Borrmann E.
    Dtsch Tierarztl Wochenschr; 2002 Apr 15; 109(4):178-82. PubMed ID: 11998370
    [Abstract] [Full Text] [Related]

  • 11. Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants.
    Lobato FC, Lima CG, Assis RA, Pires PS, Silva RO, Salvarani FM, Carmo AO, Contigli C, Kalapothakis E.
    Vaccine; 2010 Aug 31; 28(38):6125-7. PubMed ID: 20670910
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Production and evaluation of a monoclonal antibody to Clostridium perfringens type D epsilon toxin.
    El-Enbaawy MI, Abdalla YA, Hussein AZ, Osman RM, Selim SA.
    Egypt J Immunol; 2003 Aug 31; 10(1):77-81. PubMed ID: 15719625
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.